profit resulting from efficient return trip cost management. Making the company profitable, with the gross margin for the first nine months of 2020 equal to 15%, an increase from the same period last year
, “AEON Shop Plus 2019” a credit card campaign for customers to accumulate sales slips up to amounts for premium redemption, “Exclusive Trip to Japan 2019” campaign of tour package to Japan for AEON Royal
ปฏิบัติงำนท่ีมีกำรใช้อุปกรณ์เคลื่อนท่ี (mobile device) เพื่อเข้ำถึงระบบสำรสนเทศภำยในองค์กร และกำรปฏิบัติงำนจำกภำยนอกบริษัท (teleworking) 3.1 กรณีพนักงานท าการเชื่อมต่อ remote access จากที่บ้าน ผู้ประกอบ
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
% Blended 18.0 22.6 24.9 38% 10% Device Penetration 4G-handset penetration 77% 81% 80% - - Fixed Broadband Business FBB subscribers 1,336,900 1,668,900 001,772, 0 33% 6.2% FBB net addition 81,400 133,000